N-methyl-D-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 1, 1999, Pages 20-27

  Bespalov, Anton Yu ^a,b   Balster, Robert L ^a   Beardsley, Patrick M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 1 HYDROXY 2 PYRROLIDINONE; 4 (3 PHOSPHONOALLYL) 2 PIPERAZINECARBOXYLIC ACID; DIZOCILPINE; ELIPRODIL; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG TOLERANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; DISCRIMINATION LEARNING; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MORPHINE; NARCOTICS; PIPERAZINES; PIPERIDINES; PYRROLIDINONES; RATS; RATS, LONG-EVANS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032968522     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Avenet P, Leonardon J, Besnard F, Graham D, Depoortere H and Scatton B (1997) Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes. Neurosci Lett 223:133-136.
2. Balster RL, Mansbach RS, Shelton KL, Nicholson KL, Grech DM, Wiley JL, Li H and Weber E (1995) Behavioral pharmacology of two novel substituted quinoxalinedione glutamate antagonists. Behav Pharmacol 6:577-589.
3. Balster RL, Nicholson KL and Sanger DJ (1994) Evaluation of the reinforcing effects of eliprodil in rhesus monkeys and its discriminative stimulus effects in rats. Drug Alcohol Depend 35:211-216.
4. Balster RL and Willetts J (1996) Phencyclidine: A drug of abuse and a tool for neuroscience research, in Pharmacological Aspects of Drug Dependence: Towards an Integrated Neurobehavioral Approach. Handbook of Experimental Pharmacology (Schuster CR and Kuhar MJ eds) vol 118, pp 233-262, Springer-Verlag, Berlin.
5. Bespalov AY (1994) Comparative study of analgesic and reinforcing effects of excitatory amino acid receptor antagonists. Unpublished doctoral dissertation. Pavlov Medical University, Russian Federation.
6. Bespalov AY, Beardsley PM and Balster RL (1998) Interactions between N-methyl-D-aspartate receptor antagonists and the discriminative stimulus effects of morphine in rats. Pharmacol Biochem Behav 60:507-517.
7. Bhargava HN and Matwyshyn GA (1993) Dizocilpine (MK-801) blocks the tolerance to the analgesic but not to the hyperthermic effect of morphine in the rat. Pharmacology 47:344-350.
8. Colpaert FC, Kuyps JJMD, Niemegeers CJE and Janssen PAJ (1976) Discriminative stimulus properties of fentanyl and morphine: Tolerance and dependence. Pharmacol Biochem Behav 5:401-408.
9. Elliott K, Minami N, Kolesnikov YA, Pasternak GW and Inturrisi CE (1994) The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain 56:69-75.
10. Femandes M, Kluwe S and Coper H (1982) Development and loss of tolerance to morphine in the rat. Psychopharmacology 78:234-238.
11. File SE and Fernandes C (1994) Dizocilpine prevents the development of tolerance to the sedative effects of diazepam in rats. Pharmacol Biochem Behav 47:823-826.
12. Ford RD and Balster RL (1976) Schedule-controlled behavior in the morphine-dependent rat. Pharmacol Biochem Behav 4:569-573.
13. Gutstein HB and Trujillo KA (1993) MK-801 inhibits the development of morphine tolerance at spinal sites. Brain Res 626:332-334.
14. Haracz JL, Belanger SA, Macdonall JS and Sircar R (1995) Antagonists of N-methyl-D-aspartate receptors partially prevent the development of cocaine sensitization. Life Sci 57:2347-2357.
15. Herman BH, Vocci F and Bridge P (1995) The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal -Medication development issues for opiate addiction. Neuropsychopharmacology 13:269-293.
16. 9-tetrahydrocannabinol: Tolerance to the stimulus effects. Psychopharmacologia 36:243-253.
17. Kolesnikov YA, Maccechini ML and Pasternak GW (1994) 1-Aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance. Life Sci 55:1393-1398.
18. Kosten TA, Decaprio JL and Rosen MI (1995) The severity of naloxone-precipitated opiate withdrawal is attenuated by felbamate, a possible glycine antagonist. Neuropsychopharmacology 13:323-333.
19. Liljequist S (1991) The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures. Eur J Pharmacol 192:197-198.
20. Lowe DA, Neijt HC and Aebischer B (1990) D-CPP-ene (SDZ EAA 494), a potent and competitive N-methyl-D-aspartate (NMDA) antagonist: Effect on spontaneous activity and NMDA-induced depolarizations in the rat neocortical slice preparation, compared with other CPP derivatives and MK-801. Neurosci Lett 113:315-321.
21. Lutfy K, Shen KZ, Kwon IS, Cai SX, Woodward RM, Keana JF and Weber E (1995) Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist. Eur J Pharmacol 273:187-189.
22. Mansbach RS and Balster RL (1991) Pharmacological specificity of the phencyclidine discriminative stimulus in rats. Pharmacol Biochem Behav 39:971-975.
23. Marek P, Ben-Eliyahu S, Gold M and Liebeskind JC (1991a) Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res 547:77-81.
24. Marek P, Ben-Eliyahu S, Vaccarino AL and Liebeskind JC (1991b) Delayed application of MK-801 attenuates development of morphine tolerance in rats. Brain Res 558:163-165.
25. Medvedev IO, Dravolina OA and Bespalov AY (1998) Effects of N-methyl-D-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm. J Pharmacol Exp Ther 286:1260-1268.
26. Miczek KA (1991) Tolerance to the analgesic, but not discriminative stimulus effects of morphine after brief social defeat in rats. Psychopharmacology 104:181-186.
27. Ohmori T, Abekawa T, Muraki A and Koyama T (1994) Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine. Pharmacol Biochem Behav 48:587-591.
28. Preston KL and Bigelow GE (1991) Subjective and discriminative effects of drugs. Behav Pharmacol 2:293-313.
29. Rabbani M, Wright J, Butterworth AR, Zhou Q and Little HJ (1994) Possible involvement of NMDA receptor-mediated transmission in barbiturate physical dependence. Br J Pharmacol 111:89-96.
30. Rauhala P, Idänpään-Heikkilä JJ, Tuominen RK and Männistö PT (1995) Differential disappearance of tolerance to thermal, hormonal and locomotor effects of morphine in the male rat. Eur J Pharmacol 285:69-77.
31. Reisine T and Pasternak G (1996) Opioid analgesics and antagonists, in Goodman & Gilman's The Pharmacological Basis of Therapeutics (Hardman JG, Gilman AG and Limbird LE eds) pp 521-555, McGraw-Hill Book Company, New York.
32. Shoaib M, Benwell MEM, Akbar MT, Stolerman IP and Balfour DJK (1994) Behavioural and neurochemical adaptations to nicotine in rats: Influence of NMDA antagonists. Br J Pharmacol 111:1073-1080.
33. Shoaib M and Stolerman IP (1992) MK801 attenuates behavioural adaptation to chronic nicotine administration in rats. Br J Pharmacol 105:514-515.
34. Singh L, Donald AE, Foster AC, Hutson PH, Iversen LL, Iversen SD, Kemp JA, Leeson PD, Marshall GR, Oles RJ, Priestley T, Thorn L, Tricklebank MD, Vass CA and Williams BJ (1990) Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA966 is a selective glycine/N-methyl-D-aspartate receptor antagonist but (-)-HA966 is a potent γ-butyrolactone-like sedative. Proc Natl Acad Sci USA 87:347-351.
35. Steppuhn KG and Turski L (1993) Diazepam dependence prevented by glutamate antagonists. Proc Natl Acad Sci USA 90:6889-6893.
36. Szabö G, Tabakoff B and Hoffman PL (1994) The NMDA receptor antagonist dizocilpine differentially affects environment-dependent and environment-independent ethanol tolerance. Psychopharmacology 113:511-517.
37. Thorat SN and Bhargava HN (1994) Effects of NMDA receptor blockade and nitric oxide synthase inhibition on the acute and chronic actions of Delta(9)-tetrahydrocannabinol in mice. Brain Res 667:77-82.
38. Trujillo KA and Akil H (1991a) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science (Wash DC) 251:85-87.
39. Trujillo KA and Akil H (1991b) The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality. Pharmacol Biochem Behav 38:673-675.
40. Wolf ME and Jeziorski M (1993) Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res 613:291-294.
41. Wong EH, Kemp JA, Priestly T, Knight AR, Woodruff GN and Iversen LL (1986) The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 93:7104-7108.
42. Young AM, Kapitsopoulos G and Makhay MM (1991) Tolerance to morphine-like stimulus effects of Mu opioid agonists. J Pharmacol Exp Ther 257:795-805.
43. Young AM, Walton MA and Carter TL (1992) Selective tolerance to discriminative stimulus effects of morphine or d-amphetamine. Behav Pharmacol 3:201-209.